Premium
Efficacy of adjunctive therapy using Vizoovet in improving clinical signs of keratoconjunctivitis sicca in dogs: A pilot study
Author(s) -
Dees D. Dustin,
Kent Michael S.
Publication year - 2020
Publication title -
veterinary ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.594
H-Index - 50
eISSN - 1463-5224
pISSN - 1463-5216
DOI - 10.1111/vop.12763
Subject(s) - medicine , clinical significance , statistical significance , adverse effect , clinical trial , keratoconjunctivitis sicca , keratoconjunctivitis , adjunctive treatment , prospective cohort study , clinical efficacy , randomized controlled trial , surgery , ophthalmology , dermatology
Objective To assess the clinical safety and efficacy of adjunctive therapy using Vizoovet to ameliorate clinical signs of keratoconjunctivitis sicca (KCS) in dogs. Animals studied Twenty client‐owned dogs. Procedures Canine patients diagnosed with KCS were enrolled in this prospective study. Patients were randomly selected to receive either Vizoovet or GenTeal drops twice daily in addition to twice daily tacrolimus 0.03% solution. Data were collected from only one eye of each patient and included STT‐1, IOP, TFBUT, and results of objective clinical scoring performed by pet owners. Statistical significance was set at P ≤ .05. Results In all, 20 dogs (20 eyes) were enrolled in this prospective randomized study. Females (n = 12; 60%) outnumbered males (n = 8; 40%) and all dogs were spayed/neutered. Mean age of all dogs was 10.6 ± 3.79 years. In both treatment groups, the improvement in STT‐1 values over the course of the study was significant ( P = .002). When comparing the STT‐1 improvements between groups, no significance was found ( P = .78). In both groups, the improvement in TFBUT was significant ( P = .0018). When comparing the TFBUT improvements between groups, no significance was found ( P = .14). Squinting, rubbing, ocular discharge, and medication administration scores all significantly improved throughout the course of the study; however, they did not differ significantly between groups. Throughout the study, no adverse side effects were noted clinically or by the pet owner in either group. Conclusions and Clinical Relevance Adjunctive treatment with Vizoovet was as safe and effective as GenTeal drops at improving clinical signs of dry eye in dogs.